EVIDENCE FOR EARLY IMPAIRMENT OF MACULAR FUNCTION WITH PATTERN ERG IN TYPE-I DIABETIC-PATIENTS

被引:54
|
作者
CAPUTO, S
DILEO, MAS
FALSINI, B
GHIRLANDA, G
PORCIATTI, V
MINELLA, A
GRECO, AV
机构
[1] UNIV CATTOLICA SACRO CUORE, DEPT OPHTHALMOL, I-00168 ROME, ITALY
[2] UNIV CATTOLICA SACRO CUORE, DEPT INTERNAL MED, I-00168 ROME, ITALY
[3] CNR, INST NEUROPHYSIOL, ROME, ITALY
关键词
D O I
10.2337/diacare.13.4.412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The electroretinogram (ERG) elicited by alternating gratings at constant mean luminance (pattern ERG) is a focal response reflecting the activity of the directly stimulated retinal area. In addition, pattern ERG is related, unlike the flash ERG, to ganglion cell activity. Therefore, this technique may be used to evaluate the integrity of inner retinal layers in the macular region. In this study, the steady-state pattern ERG, in response to alternating gratings (1.7 cycles/deg spatial frequency; 9° field size) temporally modulated at 8 Hz, was recorded in 42 type I (insulin-dependent) diabetic patients with zero to four microaneurysms on fluorescein angiography and a duration of disease <11 yr. No patient had concomitant ocular or systemic complications. Mean pattern-ERG amplitude was significantly reduced in patients compared with age-matched control subjects (analysis of variance, F = 25.6, P < 0.0001). Significant differences were observed between control and diabetic subjects without retinopathy (Scheffé F test, P < 0.0001), between control and retinopathic subjects (Scheffé F test, P < 0.0001), and between diabetic patients without retinopathy and those with early retinopathy (Scheffé F test, P < 0.02). Pattern-ERG amplitude was inversely correlated with duration of diabetes (r = 0.22, P < 0.05). Our results suggest a macular dysfunction in early diabetes resulting from metabolic and/or vascular injuries in the neurosensory retina.
引用
收藏
页码:412 / 418
页数:7
相关论文
共 50 条
  • [1] RESPIRATORY-FUNCTION IN LONG-STANDING TYPE-I DIABETIC-PATIENTS
    BELVISO, A
    GAMBA, PL
    PALEARI, F
    GHELFI, D
    MAURI, G
    DELLATORRE, F
    RIVA, VG
    MANCIA, G
    DIABETOLOGIA, 1995, 38 : A186 - A186
  • [2] EARLY INVOLVEMENT OF CENTRAL-NERVOUS-SYSTEM TYPE-I DIABETIC-PATIENTS
    BAX, G
    LELLI, S
    GRANDIS, U
    COSPITE, AM
    PAOLO, N
    FEDELE, D
    DIABETES CARE, 1995, 18 (04) : 559 - 562
  • [3] SEVERE HYPOGLYCEMIA IN TYPE-I DIABETIC-PATIENTS WITH IMPAIRED KIDNEY-FUNCTION
    MUHLHAUSER, I
    TOTH, G
    SAWICKI, PT
    BERGER, M
    DIABETES CARE, 1991, 14 (04) : 344 - 346
  • [4] HYPOGLYCEMIC REACTION AND COMA IN TYPE-I DIABETIC-PATIENTS
    GIN, H
    ROULET, M
    BROTTIER, E
    AUBERTIN, J
    DIABETES & METABOLISM, 1984, 10 (04): : 255 - 259
  • [5] EFFECT OF INSULIN SUPPOSITORIES IN TYPE-I DIABETIC-PATIENTS
    HILDEBRANDT, R
    ILIUS, A
    LOTZ, U
    SCHLIACK, V
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1984, 83 (02): : 168 - 172
  • [6] SMOKING AND INSULIN SENSITIVITY IN TYPE-I DIABETIC-PATIENTS
    HELVE, E
    YKIJARVINEN, H
    KOIVISTO, VA
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (09): : 874 - 877
  • [7] INSULIN KINETICS IN TYPE-I AND TYPE-II DIABETIC-PATIENTS
    NAVALESI, R
    BENZI, L
    PILO, A
    MARCHETTI, P
    CECCHETTI, P
    MASONI, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1492 - 1492
  • [8] NO EVIDENCE OF LOW-BIRTH-WEIGHT AS A RISK FACTOR FOR DIABETIC NEPHROPATHY IN TYPE-I DIABETIC-PATIENTS
    ESHOJ, O
    VAAG, A
    FELDTRASMUSSEN, B
    BORCHJOHNSEN, K
    BECKNIELSEN, H
    DIABETOLOGIA, 1995, 38 : A222 - A222
  • [9] HYPORENINEMIA IS ASSOCIATED WITH ERYTHROPOIETIN DEFICIENCY IN TYPE-I DIABETIC-PATIENTS
    DONNELLY, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 448 - 448
  • [10] PREVALENCE OF SOMATIC AND AUTONOMIC NEUROPATHY IN TYPE-I DIABETIC-PATIENTS
    FRIEDLI, WG
    SCHULTZE, D
    BERGER, W
    LANGENEGGER, T
    NEUROLOGY, 1993, 43 (04) : A169 - A169